title: Olmesartan ameliorates peripheral nerve dysfunction in Zucker diabetic fatty rats.
abstract: OBJECTIVE
  Angiotensin (ANG) II type 1 receptor (AT1R) blockers have neuroprotective effects against neuronal lesions. The present study examines whether the AT1R blocker olmesartan improves peripheral nerve dysfunction in rats with type 2 diabetes.
  
  
  METHODS
  Fourteen-week-old male type 2 diabetic Zucker diabetic fatty (ZDF) rats were orally administered with olmesartan (6 mg/kg per day; n = 7) or not treated (n = 7) and then followed up for nine weeks. Age-matched and sex-matched nondiabetic lean rats served as controls (n = 7).
  
  
  RESULTS
  Olmesartan for 9 weeks did not influence blood glucose and A1c levels that were higher in untreated ZDF (U-ZDF) rats than in control rats. In U-ZDF rats, myelinated fiber density and myelin areas of myelinated fibers in peroneal nerves significantly increased and decreased, respectively, and the intraepidermal nerve fiber density (IENFD) of footpad skin tended to decrease. The U-ZDF rats developed mechanical hyperalgesia, thermal hypoalgesia and slower sensory and motor nerve conduction in the sciatic-tibial nerves. Olmesartan increased myelin areas and IENFD and ameliorated sensory nerve conduction deficits. These beneficial effects of olmesartan were associated with ANG II and insulin receptor upregulation in sensory neurons as well as deactivation of Erk1/2 in sciatic nerves.
  
  
  CONCLUSIONS
  Olmesartan appears to improve the structure and function of small and large nerves and upregulate ANG II and insulin receptors in sensory neurons of rats with type 2 diabetes.
authors: Department of Laboratory Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Japan. sugimoto@cc.hirosaki-u.ac.jp
authors: Kazuhiro
authors: K
authors: Sugimoto
authors: Keiya
authors: K
authors: Kojima
authors: Masayuki
authors: M
authors: Baba
authors: Minoru
authors: M
authors: Yasujima